AbCellera Biologics Inc. (ABCL) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$146.41M | +10.1% |
| 2024 | -$162.86M | -11.2% |
| 2023 | -$146.40M | -192.4% |
| 2022 | $158.52M | +3.3% |
| 2021 | $153.46M | +29.1% |
| 2020 | $118.92M | +5478.5% |
| 2019 | -$2.21M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$146.41M | +10.1% |
| 2024 | -$162.86M | -11.2% |
| 2023 | -$146.40M | -192.4% |
| 2022 | $158.52M | +3.3% |
| 2021 | $153.46M | +29.1% |
| 2020 | $118.92M | +5478.5% |
| 2019 | -$2.21M | — |